猪瘟病毒衣壳蛋白靶向核酸酶表达系统的建立及鉴定

根据猪瘟病毒衣壳蛋白(C)基因序列设计一对引物,RT-PCR扩增获得编码猪瘟病毒衣壳蛋白的C基因,将其插入到含有葡萄球菌核酸酶(SN)基因的真核表达载体pcDNA-SN中,筛选获得重组质粒pcDNA-C-SN。脂质体转染猪肾细胞(PK-15),并经G418稳定筛选,通过RT-PCR、免疫印迹和间接免疫荧光鉴定表达的融合蛋白,体外DNA消化试验检测核酸酶活性。结果表明融合蛋白C-SN在PK-15细胞中获得了稳定表达,能够被兔抗猪瘟病毒衣壳蛋白多抗所识别,并具有良好的核酸酶活性,能够对DNA进行切割。同时,稳定表达融合蛋白C-SN的PK-15细胞系中能够有效抑制猪瘟野毒的增殖,使其感染性降低102～103倍。这些结果为进一步将衣壳蛋白靶向病毒灭活策略应用于抵抗猪瘟病毒感染奠定了基础。     

携带猪γ干扰素基因逆转录病毒载体的构建及其在猪肾细胞(PK-15)中的表达

将梅山猪γ干扰素基因定向插入逆转录病毒载体pLXSN(neor),构建逆转录病毒重组质粒,利用脂质体介导法将重组质粒转染逆转录病毒包装细胞系PA317,转染细胞经含G418(400μg/mL)培养基筛选一周后获得稳定产毒的PA317细胞系。从细胞培养上清中提取RNA,进行RT-PCR检测,扩增到目的片段;将上清感染猪肾细胞(PK-15),经含G418(400μg/mL、600μg/mL和800μg/mL)的DMEM筛选一周,间接免疫荧光表明表达的猪γ干扰素主要锚定于细胞膜。收取PK-15细胞上清,在牛肾细胞(MDBK)上进行干扰素抗病毒活性检测,结果显示重组病毒表达的猪γ干扰素抗水泡性口炎病毒(VSV)的活性为1200IU/106cells.48h。以表达的干扰素处理PK-15细胞后,经细胞病变抑制法测定,重组猪γ干扰素可以抵抗口蹄疫病毒(FMDV)感染。试验结果表明猪γ干扰素基因已成功插入逆转录病毒基因组并在PK-15细胞中表达,表达的重组猪γ干扰素具有较强的抗病毒生物活性。     

人天然免疫基因BCL10的猪同源物的识别、克隆与初步表达分析

采用电子克隆方法克隆到大小为925 bp的人天然免疫蛋白BCL10的猪同源基因完整cDNA序列(GenBank登录号：EU088132), 并利用RT-PCR方法从猪的全血中扩增出包含702 bp的完整开放读码框架(ORF)的cDNA片段。经核酸测序, 证明与电子克隆结果相符。利用NCBI BLAST分析该cDNA包含3个大小为57 bp、289 bp和356 bp的外显子, 并且定位于猪的4号染色体上。采用半定量PCR技术检测基础水平猪各组织BCL10基因mRNA表达丰度, 并将该基因构建到带有绿色标签的真核表达载体pEGFP-C1中, 采用脂质体转染法将该基因转入PK-15细胞, 通过绿色荧光标记和RT-PCR方法检测实验组的BCL10蛋白表达。研究结果表明, BCL10基因mRNA在脾脏中表达最高; 胸腺、大脑和淋巴结表达次之, 而肝脏只有微量表达, 肾脏没有检测到表达; 同时BCL10基因在PK-15细胞中得到了有效表达。     

猪Mx1和牛Mx1蛋白在PK-15细胞中的表达及其对伪狂犬病病毒的抑制

目的:研究猪Mx1和牛Mx1蛋白在PK-15细胞中的表达并检测其是否对伪狂犬病病毒(PRV)具有抑制作用。方法:从IBRS-2细胞和MDBK细胞中分别调取猪Mx1和牛Mx1基因,并克隆到pc DNA3.1/myc-His(-)B,构建得到真核重组表达质粒,以脂质体转染的方法将其分别导入到PK-15细胞,从mRNA水平和蛋白质水平鉴定重组质粒在细胞内的表达情况,然后用细胞毒性试剂盒检测这两种蛋白是否对PK-15细胞具有毒性。之后,通过荧光定量PCR检测猪Mx1和牛Mx1在攻毒后不同时间、不同攻毒剂量的条件下对PRV的抑制情况,并观察100TCID50病毒攻击细胞72h后的病变程度。结果:成功克隆了猪Mx1和牛Mx1基因,经mRNA水平和蛋白质水平证实,两种重组质粒在PK-15细胞内能够正常表达。从荧光定量PCR和细胞病变的角度来看,细胞内表达的Mx1蛋白对PRV具有显著性的抑制(P0.001)。结论:猪Mx1和牛Mx1基因在PK-15细胞中表达的Mx1蛋白能够抑制PRV在胞内的复制。     

猪CD151转基因PK-15细胞系构建及其对猪繁殖与呼吸综合征病毒的易感性

[目的]建立猪繁殖与呼吸综合征病毒(porcine reproductive and respiratory syndrome virus,PRRSV)易感的猪CD151转基因PK-15细胞系,研究CD151分子在PRRSV感染猪源细胞中的作用.[方法]用RT-PCR从猪肺泡巨噬细胞中扩增CD151全长cDNA,测序正确后克隆人真核表达载体pcDNA3;用重组载体pcDNA-CD151转染PK-15细胞,经G418抗性筛选获得转基因细胞系PK15-CD151,用RT-PCR和免疫荧光试验检测CD151表达;用VR-2332株PRRSV分别感染PK-15细胞、PK15-CD151细胞、MARC-145细胞和3D4-CD163细胞,定期观察细胞病变,用RT-PCR和免疫荧光试验检测病毒RNA基因组和病毒抗原,用半数组织细胞感染剂量测定病毒滴度.[结果]从猪巨噬细胞中克隆得序列正确的猪CD151 cDNA;从重组载体转染的PK-15细胞培养中筛选得G418抗性细胞克隆,并能正确表达猪CD151分子;在PRRSV感染后,PK15-CD151细胞虽然不表现明显的细胞病变,但能检测到病毒RNA基因组和病毒抗原,并能产生较高滴度的感染性病毒;该细胞系已在体外传30代以上,第10、20、30代细胞的PRRSV滴度无明显变化.[结论]猪CD151基因转染能使非易感PK-15细胞获得对PRRSV的易感性,提示猪CD151参与PRRSV感染猪源细胞.     

逆转录病毒载体介导的猪瘟病毒配基因的真核表达

利用DNA重组技术将猪瘟病毒(Classicalswinefevervirus,CSFV)石门株囊膜蛋白E2基因插入逆转录病毒载体pBABE-puro中构建成重组逆转录病毒载体pBABE-puro-E2,该重组逆转录病毒载体与pVSVg质粒经磷酸钙共转染法将其转入293GP细胞中包装逆转录病毒假病毒。用包装的假病毒感染PK-15细胞,经嘌呤霉素筛选阳性细胞后进行流式细胞技术(FACS)分析,结果表明CSFVE2基因在PK-15细胞膜上成功表达。将表达E2蛋白的PK-15细胞腹腔免疫Balb/c小鼠,成功诱导小鼠产生了抗E2蛋白的抗体。     

逆转录病毒载体介导的猪瘟病毒E2基因的真核表达

利用DNA重组技术将猪瘟病毒(Classical swine fever virus , CSFV)石门株囊膜蛋白E2基因插入逆转录病毒载体pBABE-puro 中构建成重组逆转录病毒载体pBABE-puro-E2,该重组逆转录病毒载体与pVSVg质粒经磷酸钙共转染法将其转入293GP细胞中包装逆转录病毒假病毒.用包装的假病毒感染PK-15细胞,经嘌呤霉素筛选阳性细胞后进行流式细胞技术(FACS)分析,结果表明CSFV E2基因在PK-15细胞膜上成功表达.将表达E2蛋白的PK-15细胞腹腔免疫Balb/c小鼠,成功诱导小鼠产生了抗E2蛋白的抗体.     

基于流式细胞术分选的高效表达外源基因细胞的筛选

目的：以增强型绿色荧光蛋白（EGFP）作为报告基因,用流式细胞术筛选高表达EGFP的细胞,从而获得外源基因高效表达细胞株。方法：构建在EGFPC端编码区融合新霉素（neomycin）抗性基因的融合基因EGFP-Neomycin,将其插入pcDNA3.1（＋）载体,构建EGFP-Neomycin融合基因表达载体pcDNAEN,转染CHO-K1细胞,G418加压筛选和倒置荧光显微镜观察证实所表达的EGFP-Neomycin融合蛋白具有新霉素抗性和激发EGFP荧光双功能;将编码组织型纤溶酶原激活剂（tPA）的cDNA插入pcDNAEN中CMV启动子下游,构建表达tPA的表达载体pcDNAEN/tPA。结果：流式细胞术分析和tPA纤维蛋白溶解活性测定表明,pcDNAEN/tPA转染CHO-K1细胞的EGFP相对荧光强度（RFT）的自然对数值与tPA表达水平呈明显的直线相关关系,相关系数为0.983;比较部分未经流式细胞仪分选的pcDNAEN/tPA转染阳性细胞克隆和RFT分布在100～1000的pcDNAEN/tPA转染阳性细胞克隆的tPA表达水平,经流式细胞术分选获得的细胞克隆的tPA平均表达水平和最高表达水平分别是未经分选获得的细胞克隆的3.9倍和4.1倍。结论：构建的EGFP-Neomycin融合基因具有双功能,建立了利用流式细胞术筛选外源基因高效表达物细胞株的方法。     

猪伪狂犬病毒Fa株侵染对PK-15细胞microRNAs表达谱的影响

【目的】分析猪伪狂犬病毒Fa株(PRV-Fa)侵染对猪肾传代细胞PK-15 microRNAs(miRNAs)表达谱的影响。【方法】利用Illumina高通量测序技术,鉴定感染和非感染PRV-Fa的PK-15细胞的miRNAs;筛选并利用实时荧光定量RT-PCR(RT-q PCR)验证差异表达miRNAs;对差异miRNAs进行靶基因预测和Gene ontology(GO)分析。【结果】在感染和未感染PK-15细胞中分别检测到384个和405个miRNAs,其中感染PRV-Fa后差异表达的miRNAs共127个(60个上调,67个下调)。荧光定量结果显示差异miRNAs的表达趋势与高通量测序结果一致。GO分析显示,miRNAs广泛参与信号传导、细胞代谢、免疫反应、基因表达等生物学进程,其中miR-10b、miR-16、miR-18a、miR-19b、miR-20a、miR-145-5p、miR-146a、miR-181a、miR-499-5p等miRNAs与免疫相关。在靶基因调控网络图中,ssc-miR-30a-5p与ssc-miR-30d处于关键位置。研究鉴定出5个新的病毒编码miRNAs,其中PRV-miR-LLT2与PRV-miR-LLT4靶向PRV早期蛋白基因EPO。【结论】伪狂犬病毒Fa株感染对PK-15细胞编码miRNAs有显著影响。     

IL-2与猪细小病毒VP2基因双表达载体的构建及免疫原性的研究

将白细胞介素-2基因和猪细小病毒VP2基因主要抗原区克隆至pCI-neo真核表达载体中,构建了pCIneo-IL2-VP2重组质粒,用脂质体将其转染到PK-15细胞中,利用免疫荧光方法检测在体外表达情况。并以小鼠为动物模型,将pCIneo-IL2-VP2重组质粒、对照组pCI-neo和猪细小病毒活疫苗通过肌肉注射进行免疫,检测免疫小鼠的淋巴细胞转化功能,特异性CTL杀伤活性和血清抗体滴度。结果显示,pCIneo-IL2-VP2在体外能够诱导PK-15细胞表达VP2蛋白,小鼠注射pCIneo-IL2-VP2质粒1周后能够诱导机体产生抗体,4周时达到峰值,与活疫苗对照组产生的抗体滴度、诱导T淋巴细胞增殖和诱导强的细胞毒性基本一致。试验表明,构建的pCIneo-IL2-VP2能够有效诱导机体产生体液免疫和细胞免疫。     

GBP3 promotes glioma cell proliferation via SQSTM1/p62-ERK1/2 axis

Guanylate binding proteins (GBPs) are interferon-inducible large GTPases and play a crucial role in cell-autonomous immunity. However, the biology function of GBPs in cancer remains elusive. GBP3 is specifically expressed in adult brain. Here we show that GBP3 is highly elevated in human glioma tumors and glioma cell lines. Overexpression of GBP3 dramatically increased glioma cell proliferation whereas silencing GBP3 by RNA interference produced opposite effects. We further showed that GBP3 expression was able to induce sequestosome-1(SQSTM1, also named p62) expression and activate extracellular signal-regulated kinase (ERK1/2). The SQSTM1-ERK1/2 signaling cascade was essential for GBP3-promoted cell growth because depletion of SQSTM1 markedly reduced the phosphorylated ERK1/2 levels and GBP3-mediated cell growth, and inhibition of mitogen-activated protein kinase/ERK kinase abolished GBP3-induced glioma cell proliferation. Consistently, GBP3 overexpression significantly promoted glioma tumor growth in vivo and its expression was inversely correlated with the survival rate of glioma patients. Taken together, these results for the first time suggest that GBP3 contributes to the proliferation of glioma cells via regulating SQSTM1-ERK1/2 pathway, and GBP3 might represent as a new potential therapeutic target against glioma.     

Plasma GBP2 promoter methylation is associated with advanced stages in breast cancer

Blood methylated cell-free DNA (cfDNA) as a minimally invasive cancer biomarker has great importance in cancer management. Guanylate binding protein 2 (GBP2) has been considered as a possible controlling factor in tumor development. GBP2 gene expression and its promoter methylation status in both plasma cfDNA and tumor tissues of ductal carcinoma breast cancer patients were analyzed using SYBR green comparative Real-Time RT-PCR and, Methyl-specific PCR techniques, respectively in order to find a possible cancer-related marker. The results revealed that GBP2 gene expression and promoter methylation were inversely associated. GBP2 was down-regulated in tumors with emphasis on triple negative status, nodal involvement and higher cancer stages (p<0.0001). GBP2 promoter methylation on both cfDNA and tumor tissues were positively correlated and was detected in about 88% of breast cancer patients mostly in (Lymph node positive) LN+ and higher stages. Data provided shreds of evidence that GBP2 promoter methylation in circulating DNA may be considered as a possible effective non-invasive molecular marker in poor prognostic breast cancer patients with the evidence of its relation to disease stage and lymph node metastasis. However further studies need to evaluate the involvement of GBP2 promoter methylation in progression-free survival or overall survival of the patients.     

p53对TGEV感染PK-15细胞4种免疫调节因子mRNA转录水平的影响

为探究p53对IFN-α、MIP-1α、PGK-1、TGF-β1四种免疫调节因子在TGEV感染PK-15细胞中的影响,本研究首先采用CRISPR-Cas9慢病毒系统靶向于PK-15细胞的p53基因构建p53基因敲除(p53-/-)的细胞;再以感染复数为0.1 MOI的TGEV感染p53野生型(p53+/+)和p53-/-PK-15细胞,于不同的感染时间收集细胞并提取细胞总RNA,应用实时荧光定量PCR(qRT-PCR)技术检测四种细胞因子的转录水平。结果表明,构建的靶向于p53基因敲除的PK-15细胞中,p53基因的454碱基位点缺失一个碱基T,细胞的p53蛋白已检测不到;TGEV感染后IFN-αmRNA的相对表达量在两种细胞中均表现为先上升后下降的趋势,但在病毒感染的36 h之前,p53-/-PK-15细胞中的表达量显著低于p53+/+PK-15细胞(p<0.05);MIP-1αmRNA相对表达量随着病毒感染时间的推移而递增,且在p53+/+PK-15细胞中显著高于p53-/-PK-15细胞(p<0.05);TGF-β1 mRNA的相对表达量在p53+/+PK-15细胞中随时间推移总体呈递减趋势,并在病毒感染(post infection,p.i.)12 h之后显著低于p53-/-PK-15细胞(p<0.05);PGK-1 mRNA相对表达量在病毒感染的12 h p53+/+PK-15细胞中虽略有上升,但差异不显著,而在p53-/-PK-15细胞中呈现时间依赖性递增,并显著高于p53+/+PK-15细胞(p<0.05)。以上结果表明:p53对TGEV感染PK-15细胞后的细胞免疫因子起到了关键的调节作用,推测其可能在宿主抗TGEV感染中发挥着重要作用。     

Downregulation of immune response by the human cytokines Interleukin-32α and β in cell-mediated rejection

Xenotransplantation of porcine organs has the potential to help overcome the severe shortage of human tissues and organs available for human transplantation. However, numerous hurdles such as immune-mediated xenograft rejection remain before clinical xenotransplantation.In this study, we elucidated the role of human TNF-α-inducing factor, Interleukin-32 (IL-32), in porcine kidney cells (PK-15) during cell-mediated rejection by examining host cell responses. CD8⁺ and CD4⁺ T cells numbers were reduced in the lymph nodes of PK-15/IL-32β injected mice. CD3⁺ Tcells were in mice injected with control cells but PK-15/IL-32α- and PK-15/IL-32β-injected cell numbers were lower in lymphnodes than un transfected controls. In Mixed lymphocyte reaction cultures, the rates of cell proliferation were increased in both PK-15/IL-32α- and PK-15/IL-32β-injected groups compared to the untransfected control groups. The Stable porcine PK-15 cells expression IL-32α and IL-32β inhibited cytotoxic T lymphocyte (CTLs) after cellular xenograft. Our results suggest that human IL-32α and IL-32β regulates on xenograft rejection in cellular xenotransplantation.     

猪Ⅱ型圆环病毒四川分离株鉴定及其ORF2基因序列分析

猪圆环病毒(Porcine circovirus,PCV),属于圆环病毒科(Circoviridae),圆环病毒属(Circovirus),血清型为PCV-1和PCV-2[1]。PCV-1首先由Tis-cher[2]于1974年从PK-15猪肾传代细胞系中分离获得,PCV-2首先由Clark[3]报道了是断奶仔猪多系统衰竭综合征(PMWS)的主要病原,随即相继报道了PCV-2与PDNSS(猪皮炎与肾炎综合症)、NP(增生性坏死性肿炎)、PRDC(猪呼吸道综合征)、繁殖障碍、先天性颤抖、肠炎等疾病亦有重要关联[4,5];它常与猪呼吸与繁殖综合征病毒(PRRSV)或猪细小病毒(PPV)并发感染或继发细菌感染[6]。我国自从2000年郎…     

应用RNA干扰沉默猪内源性反转录病毒

目的:尝试应用RNA干扰(RNAi)沉默猪源PK-15细胞中的猪内源性反转录病毒(PERV),并通过反转录酶活性及pol基因相对荧光定量PCR检测沉默效果。方法:依据GenBank公布的PERV pol基因序列,采用Invitro-gen公司的BLOCK-iT RNAi Designer软件设计Stealth小干扰RNA(siRNA)序列;将合成的siRNA转染PK-15细胞,72 h后检测细胞上清PERV反转录酶活性及细胞内pol基因拷贝数并评价沉默效果。结果:反转录酶活性及pol基因拷贝数检测结果表明,设计的3条Stealth siRNA序列中,位于pol基因3272～3296 bp的序列能有效沉默PERV。结论:RNAi方法可有效使猪源PK-15细胞中的PERV沉默,为进一步研究天然抗病毒分子与PERV的相互作用提供了实验基础,同时也为猪源异种移植研究中去除PERV提供了一种可供尝试的方法。     

The design and recombinant protein expression of a consensus porcine interferon: CoPoIFN-α

CoPoIFN-α is a recombinant non-naturally occurring porcine interferon-α (IFN-α). It was designed by scanning 17 porcine IFN-α nonallelic subtypes and assigning the most frequently occurring amino acid in each position. We used a porcine IFN-α (PoIFN-α) derived from domestic pig as a control. Both porcine IFN-α genes were introduced into yeast expression vector PpICZα-A and expressed in Pichia pastoris. The antiviral unit of these two IFN-αs were assayed in MDBK, PK-15 and MARC-145 cells against vesicular stomatitis virus (VSV), and their inhibitory abilities on pseudorabies virus (PRV) and porcine reproductive and respiratory syndrome virus (PRRSV) replication were also examined, respectively. We found the antiviral activity (units/mg) of CoPoIFN-α was 46.4, 63.6 and 53.5-fold higher than that of PoIFN-α for VSV inhibition in MDBK, PK-15 and MARC-145 cells, 4.8-fold higher for PRV inhibition in PK-15 cells, and 5-fold higher for PRRSV inhibition in MARC-145 cells. Our results also showed that the PRV and PRRSV-specific cytopathic effect (CPE) could be inhibited in the cells pretreated with CoPoIFN-α and PoIFN-α, and the virus titers in the cells pretreated with CoPoIFN-α were lower than those cells pretreated with PoIFN-α by 10-20-fold. The antiproliferative activity of CoPoIFN-α was significantly higher than that of PoIFN-α on a molar basis. The mRNA level of Mx1 and OAS1 genes in PK-15 cells induced by CoPoIFN-α were enhanced about 4.6-fold and 3.2-fold compared to that induced by PoIFN-α. Based on a homology model of CoPoIFN-α and IFNAR2, all of the different residues between native PoIFN-α and CoPoIFN-α were not involved in IFNAR1 binding site, and there is no direct interaction between these residues and IFNAR2, either. We speculate that the higher activity of CoPoIFN-α was likely due to the electrostatic potential introduced by residue Arg156 around the binding site or a structural perturbation caused by these different residues. This may enhance the overall binding affinity of CoPoIIFN-α and the receptors. Thus, CoPoIFN-α may have the potential to be used in therapy of porcine diseases.     

Insect cytokine growth-blocking peptide signaling cascades regulate two separate groups of target genes

Growth-blocking peptide (GBP) is a 25 amino acid insect cytokine found in lepidopteran insects that has diverse biological activities, such as larval growth regulation, paralysis induction, cell proliferation, and stimulation of immune cells. GBP also enhances expression of the tyrosine hydroxylase (TH, EC 1.14.16.2) and 3,4-dihydroxy-l-phenylalanine (Dopa) decarboxylase (DDC, EC 4.1.1.26) genes, which elevate dopamine levels in insect epidermal cells. We used insect epidermis and cultured cells to define the role of the GBP signaling pathway in the enhancement of TH and DDC gene expression. It has been recently reported that robust expression of the DDC gene requires activation of extracellular signal-regulated kinase (ERK) in epidermal cells of wounded Drosophila embryos. This study confirmed that GBP activates ERK, but this activation is not directly linked to the enhancement of TH and DDC gene expression. One of the GBP pathway components is phospholipase C, whose activation is essential for the activation of ERK and elevation of expression of both enzyme genes. The downstream signaling pathways diverge to ERK activation through activated protein kinase C and expression of the enzyme genes through inositol triphosphate receptor-mediated Ca2+ influx from extracellular fluid. Our data indicate that the diverged GBP signaling pathways enable GBP to exert completely different biological functions, even in a single cell type.